Literature DB >> 17696252

Spontaneous elimination of hepatitis C virus infection: a retrospective study on demographic, clinical, and serological correlates.

Perdita Wietzke-Braun1, Larissa-Bettina Manhardt, Albert Rosenberger, Angela Uy, Giuliano Ramadori, Sabine Mihm.   

Abstract

AIM: To find correlates to spontaneous clearance of hepatitis C virus (HCV) infection, this study compared individuals with self-limited and chronic infection with regard to clinical, demographic, and serological parameters.
METHODS: Sixty-seven anti-HCV positive and repeatedly HCV RNA negative individuals were considered to have resolved HCV infection spontaneously. To determine the viral genotype these patients had been infected with HCV serotyping was performed. For comparison reasons, 62 consecutive patients with chronic hepatitis C were enrolled. Cases and controls were compared stratified for age and sex.
RESULTS: Retrospective analysis showed (1) a lower humoral reactivity to HCV in patients with self-limited compared to chronic HCV-infection and (2) that younger age, history of iv drug use, and acute/post-acute hepatitis A or B co-infections, but not viral genotypes, are independent correlates for spontaneous HCV clearance.
CONCLUSION: The stronger humoral reactivity to HCV in patients with persistent infections and in those with a history of iv drug use is supposed to be due to continuous or repeated contact(s) to the antigen. Metachronous hepatitis A or hepatitis B infections might favor HCV clearance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17696252      PMCID: PMC4250622          DOI: 10.3748/wjg.v13.i31.4224

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

1.  Diagnosis, management, and treatment of hepatitis C.

Authors:  Doris B Strader; Teresa Wright; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

2.  Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6.

Authors:  V Bhattacherjee; L E Prescott; I Pike; B Rodgers; H Bell; A R El-Zayadi; M C Kew; J Conradie; C K Lin; H Marsden
Journal:  J Gen Virol       Date:  1995-07       Impact factor: 3.891

3.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Authors:  M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

4.  Protection against persistence of hepatitis C.

Authors:  Shruti H Mehta; Andrea Cox; Donald R Hoover; Xiao-Hong Wang; Qing Mao; Stuart Ray; Steffanie A Strathdee; David Vlahov; David L Thomas
Journal:  Lancet       Date:  2002-04-27       Impact factor: 79.321

5.  Hepatitis C virus superinfection in hepatitis B virus chronic carriers: a reciprocal viral interaction and a variable clinical course.

Authors:  Evangelista Sagnelli; Nicola Coppola; Cecilia Marrocco; Mirella Onofrio; Caterina Sagnelli; Giancarlo Coviello; Carlo Scolastico; Pietro Filippini
Journal:  J Clin Virol       Date:  2005-11-28       Impact factor: 3.168

6.  Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.

Authors:  P Simmonds; K A Rose; S Graham; S W Chan; F McOmish; B C Dow; E A Follett; P L Yap; H Marsden
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

7.  Morphine enhances hepatitis C virus (HCV) replicon expression.

Authors:  Yuan Li; Ting Zhang; Steven D Douglas; Jian-Ping Lai; Wei-Dong Xiao; David E Pleasure; Wen-Zhe Ho
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

8.  Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response.

Authors:  Norbert H Gruener; Maria-Christina Jung; Axel Ulsenheimer; Tilman J Gerlach; Helmut M Diepolder; Carl A Schirren; Robert Hoffmann; Martin Wächtler; Markus Backmund; Gerd R Pape
Journal:  J Hepatol       Date:  2002-12       Impact factor: 25.083

9.  Genetic variability of hepatitis C virus in HBV/HCV co-infection and HCV single-infection.

Authors:  M S De Mitri; G Morsica; R Cassini; S Bagaglio; P Andreone; G Bianchi; M Margotti; M Bernardi
Journal:  Arch Virol       Date:  2004-10-11       Impact factor: 2.574

10.  Hepatitis C virus (HCV) genotype distribution in German isolates: studies on the sequence variability in the E2 and NS5 region.

Authors:  G Driesel; D Wirth; K Stark; R Baumgarten; U Sucker; E Schreier
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more
  10 in total

1.  Natural evolution of hepatitis C virus infection in hemodialysis Tunisian patients and CTLA-4 SNP's.

Authors:  Leila Ksiaa Cheikhrouhou; Yousr Lakhoua-Gorgi; Imen Sfar; Salwa Jendoubi-Ayed; Houda Aouadi; Mouna Makhlouf; Khaled Ayed; Taieb Ben Abdallah
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

2.  Dynamic coinfection with multiple viral subtypes in acute hepatitis C.

Authors:  Jennifer A Smith; Judith H Aberle; Vicki M Fleming; Peter Ferenci; Emma C Thomson; Peter Karayiannis; Angela R McLean; Heidemarie Holzmann; Paul Klenerman
Journal:  J Infect Dis       Date:  2010-11-10       Impact factor: 5.226

3.  [Spontaneous remission of HCV infection after autologous stem cell transplantation in a 58-year-old man].

Authors:  L Reinhardt; H Eiffert; G Wulf; P Ströbel; S C B Bremer; A Amanzada; V Ellenrieder; A Neesse
Journal:  Internist (Berl)       Date:  2017-06       Impact factor: 0.743

4.  Characterization of linear epitope specificity of antibodies potentially contributing to spontaneous clearance of hepatitis C virus.

Authors:  Asma Ahsan; Saira Dar; Fareeha Hassan; Farkhanda Ghafoor; Muhammad Haroon Yousuf; Syed Shahzad-Ul-Hussan
Journal:  PLoS One       Date:  2021-08-27       Impact factor: 3.240

5.  Hepatitis C Virus Genotype Analyses in Chronic Hepatitis C Patients and Individuals With Spontaneous Virus Clearance Using a Newly Developed Serotyping Assay.

Authors:  Ruifeng Yang; Xiqin Yang; Bingshui Xiu; Huiying Rao; Ran Fei; Wenli Guan; Yan Liu; Qian Wang; Xiaoyan Feng; Heqiu Zhang; Lai Wei
Journal:  J Clin Lab Anal       Date:  2016-06-13       Impact factor: 2.352

Review 6.  Virus-related liver cirrhosis: molecular basis and therapeutic options.

Authors:  Ji Lin; Jian-Feng Wu; Qi Zhang; Hong-Wei Zhang; Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

7.  The impact of illicit drug use on spontaneous hepatitis C clearance: experience from a large cohort population study.

Authors:  Hossein Poustchi; Saeed Esmaili; Ashraf Mohamadkhani; Aghbibi Nikmahzar; Akram Pourshams; Sadaf G Sepanlou; Shahin Merat; Reza Malekzadeh
Journal:  PLoS One       Date:  2011-08-24       Impact factor: 3.240

8.  Factors associated with spontaneous clearance of hepatitis C virus in Chinese population.

Authors:  Fei Kong; Yu Pan; Xiumei Chi; Xiaomei Wang; Linjiao Chen; Juan Lv; Haibo Sun; Ruihong Wu; Jinglan Jin; Ge Yu; Zhenhua Ma; Yang Wang; Xinxing Huang; Hua Li; Yang Bai; Jing Jia; Gerald Y Minuk; Jin Zhong; Bing Sun; Jing Jiang; Junqi Niu
Journal:  Biomed Res Int       Date:  2014-07-16       Impact factor: 3.411

9.  IL28B gene polymorphisms and US liver fatty changes in patients who spontaneously cleared hepatitis C virus infection.

Authors:  Gloria Taliani; Martina Spaziante; Elisa Biliotti; Marina Borro; Donatella Palazzo; Stefania Grieco; Cristiana Franchi; Giancarlo Iaiani; Caterina Furlan; Valentina Gallinaro; Maurizio Simmaco
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

10.  Spontaneous clearance of hepatitis C virus after liver transplantation: a report of four cases.

Authors:  Ichiro Tamaki; Toshimi Kaido; Shintaro Yagi; Yoshihide Ueda; Etsuro Hatano; Hideaki Okajima; Shinji Uemoto
Journal:  Surg Case Rep       Date:  2015-12-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.